530 related articles for article (PubMed ID: 7709948)
1. Association of serum C3 levels with the risk of myocardial infarction.
Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
[TBL] [Abstract][Full Text] [Related]
2. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
Engström G; Hedblad B; Janzon L; Lindgärde F
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
[TBL] [Abstract][Full Text] [Related]
3. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
Muscari A; Massarelli G; Bastagli L; Poggiopollini G; Tomassetti V; Drago G; Martignani C; Pacilli P; Boni P; Puddu P
Eur Heart J; 2000 Jul; 21(13):1081-90. PubMed ID: 10843826
[TBL] [Abstract][Full Text] [Related]
4. [Association of serum C3 and essential hypertension].
Bozzoli C; Muscari A; Puddu GM; Rovinetti C; Renzi C; Vallar G; Puddu P
G Ital Cardiol; 1992 Dec; 22(12):1361-6. PubMed ID: 1294420
[TBL] [Abstract][Full Text] [Related]
5. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
[TBL] [Abstract][Full Text] [Related]
6. Complement and immunoglobulin levels in Ilorin Nigeria, and environ.
Oyeyinka GO; Aiyedun BA; Erasmus RT; Adewoye HO; Adetoro OO; Adedoyin MA
Afr J Med Med Sci; 1995 Mar; 24(1):9-16. PubMed ID: 7495207
[TBL] [Abstract][Full Text] [Related]
7. [Serum C3 as a screening factor in the primary prevention of myocardial infarct].
Muscari A; Massarelli G; Puddu GM; Sangiorgi Z; Dormi A; Bagnoli M; Gaddi A; Puddu P
Cardiologia; 1995 Jul; 40(7):507-14. PubMed ID: 8529255
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
[TBL] [Abstract][Full Text] [Related]
9. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
10. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
Yue H; Gu DF; Wu XG; Yu XH; Duan XF; Wang JH; Zheng RP; Zhou J
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):43-6. PubMed ID: 14989905
[TBL] [Abstract][Full Text] [Related]
11. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
[TBL] [Abstract][Full Text] [Related]
12. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study.
Engström G; Hedblad B; Berglund G; Janzon L; Lindgärde F
J Hum Hypertens; 2007 Apr; 21(4):276-82. PubMed ID: 17167524
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
15. Negative and positive predictive values of routine exercise testing in stable, medically-treated patients several years following a Q-wave myocardial infarction.
Casella G; Pavesi PC; Niro MD; Bracchetti D
Ital Heart J; 2001 Apr; 2(4):271-9. PubMed ID: 11374496
[TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
Cagatay T; Bilir M; Gulbaran M; Papila C; Cagatay P
Kobe J Med Sci; 2003; 49(5-6):99-106. PubMed ID: 15141145
[TBL] [Abstract][Full Text] [Related]
17. Association between electrocardiographic ischemic abnormalities and ischemic heart disease risk factors in a Japanese population.
Choudhury SR; Yoshida Y; Kita Y; Nozaki A
J Hum Hypertens; 1996 Apr; 10(4):225-34. PubMed ID: 8736453
[TBL] [Abstract][Full Text] [Related]
18. Complement as a predictor of further miscarriage in couples with recurrent miscarriages.
Sugiura-Ogasawara M; Nozawa K; Nakanishi T; Hattori Y; Ozaki Y
Hum Reprod; 2006 Oct; 21(10):2711-4. PubMed ID: 16790609
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulins and complement components in patients with lung cancer.
Oner F; Savaş I; Numanoğlu N
Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
[TBL] [Abstract][Full Text] [Related]
20. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
